• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

局部应用眼科药物的药代动力学。

Pharmacokinetics of topically applied ophthalmic drugs.

作者信息

Shell J W

出版信息

Surv Ophthalmol. 1982 Jan-Feb;26(4):207-18. doi: 10.1016/0039-6257(82)90081-9.

DOI:10.1016/0039-6257(82)90081-9
PMID:7041308
Abstract

Pharmacokinetic applications in recent years have led to significant advances in systemic drug therapy, but applications to topical, ophthalmic therapy have been far less numerous. Pharmacokinetics is the study of the time course of the absorption, distribution, metabolism, and elimination of an administered drug. Thus, it includes the quantitation of such elements of drug bioavailability as tear dilution, drug binding, and vehicle effects; factors affecting corneal absorption and subsequent tissue distribution; dosage form effects; and pathways of elimination. These factors are important because they significantly influence the clinical responses to administered drugs, in some instances to a profound degree. These elements and their clinical implications are discussed along with some recent applications, exemplified with data from studies on frequently prescribed drugs.

摘要

近年来,药代动力学在全身药物治疗方面取得了重大进展,但在局部、眼科治疗中的应用却少得多。药代动力学是研究给药药物的吸收、分布、代谢和消除的时间过程。因此,它包括对药物生物利用度的一些要素进行定量,如泪液稀释、药物结合和载体效应;影响角膜吸收及随后组织分布的因素;剂型效应;以及消除途径。这些因素很重要,因为它们在某些情况下会对给药药物的临床反应产生重大影响,有时影响程度很深。本文将讨论这些要素及其临床意义,并结合一些近期的应用实例进行说明,这些实例的数据来自对常用药物的研究。

相似文献

1
Pharmacokinetics of topically applied ophthalmic drugs.局部应用眼科药物的药代动力学。
Surv Ophthalmol. 1982 Jan-Feb;26(4):207-18. doi: 10.1016/0039-6257(82)90081-9.
2
Influence of topical anesthesia on tear dynamics and ocular drug bioavailability in albino rabbits.
J Pharm Sci. 1975 Feb;64(2):267-71. doi: 10.1002/jps.2600640215.
3
Ocular bioavailability and systemic loss of topically applied ophthalmic drugs.局部应用眼科药物的眼部生物利用度和全身损失。
Am J Ophthalmol. 1978 Feb;85(2):225-9. doi: 10.1016/s0002-9394(14)75953-7.
4
Vehicle effects on ocular drug bioavailability II: Evaluation of pilocarpine.
J Pharm Sci. 1977 Sep;66(9):1222-8. doi: 10.1002/jps.2600660905.
5
Amniotic membrane, tear film, corneal, and aqueous levels of ofloxacin in rabbit eyes after amniotic membrane transplantation.羊膜移植后兔眼羊膜、泪膜、角膜及房水中氧氟沙星的含量
Cornea. 2001 Aug;20(6):628-34. doi: 10.1097/00003226-200108000-00014.
6
Ocular penetration of topical chloramphenicol in humans.局部应用氯霉素在人体中的眼部渗透情况。
Arch Ophthalmol. 1978 Jul;96(7):1258-61. doi: 10.1001/archopht.1978.03910060084018.
7
Ocular pharmacokinetics of besifloxacin following topical administration to rabbits, monkeys, and humans.贝西沙星对兔、猴和人进行局部给药后的眼药代动力学。
J Ocul Pharmacol Ther. 2009 Aug;25(4):335-44. doi: 10.1089/jop.2008.0116.
8
Availability of 0.3% ofloxacin ointment and solution in human conjunctiva and aqueous humor.人结膜和房水中0.3%氧氟沙星眼膏和滴眼液的药物可得性。
J Ocul Pharmacol Ther. 1995 Spring;11(1):57-63. doi: 10.1089/jop.1995.11.57.
9
Ocular pharmacokinetics and availability of topically applied baicalein in rabbits.兔眼局部应用黄芩苷的药代动力学及药物可利用度
Curr Eye Res. 2009 Apr;34(4):257-63. doi: 10.1080/02713680902725962.
10
Ocular surface distribution and pharmacokinetics of a novel ophthalmic 1% azithromycin formulation.新型眼科 1%阿奇霉素制剂的眼部表面分布和药代动力学。
J Ocul Pharmacol Ther. 2009 Oct;25(5):433-9. doi: 10.1089/jop.2009.0026.

引用本文的文献

1
Comparison of Subconjunctival Triamcinolone with Topical Prednisolone for Routine Anti-Inflammatory Prophylaxis in Manual Small Incision Cataract Surgery: A Single-Center, Randomized Controlled Trial Pilot Protocol.结膜下注射曲安奈德与局部应用泼尼松龙在手法小切口白内障手术中进行常规抗炎预防的比较:一项单中心随机对照试验的试验方案
Clin Ophthalmol. 2025 Jul 4;19:2091-2105. doi: 10.2147/OPTH.S527039. eCollection 2025.
2
Topical Ocular Drug Delivery: The Impact of Permeation Enhancers.眼部局部给药:渗透促进剂的影响
Pharmaceutics. 2025 Mar 31;17(4):447. doi: 10.3390/pharmaceutics17040447.
3
Preserved bevacizumab (Avastin®) eye drops for application in multidose containers - an in-vitro characterisation.
用于多剂量容器的保存型贝伐单抗(阿瓦斯汀®)滴眼液——体外特性研究
BMC Vet Res. 2025 Mar 1;21(1):129. doi: 10.1186/s12917-025-04592-4.
4
Optimizing instilled drug delivery: a scoping review of microdrops in ophthalmology.优化滴眼剂给药:眼科微滴的范围综述
Graefes Arch Clin Exp Ophthalmol. 2025 Feb 26. doi: 10.1007/s00417-025-06773-1.
5
Development of sustained-release extemporaneous moxifloxacin loaded commercial soft hydrogel contact lenses.载有莫西沙星的即配型缓释商用软性水凝胶隐形眼镜的研发。
Heliyon. 2025 Feb 1;11(3):e42436. doi: 10.1016/j.heliyon.2025.e42436. eCollection 2025 Feb 15.
6
Extracellular vesicles for corneal regeneration: the new frontier.用于角膜再生的细胞外囊泡:新前沿
Regen Med. 2024 Nov;19(11):519-522. doi: 10.1080/17460751.2024.2412510. Epub 2024 Oct 18.
7
An Unusual Case of Paroxysmal Third-Degree Atrioventricular Block: Thinking Outside the Box.一例罕见的阵发性三度房室传导阻滞病例:跳出框框思考。
Cureus. 2024 Jun 20;16(6):e62782. doi: 10.7759/cureus.62782. eCollection 2024 Jun.
8
Conjunctival and nasal microflora in patients on topical cyclosporine for dry eye.眼干燥症患者局部应用环孢素后的结膜和鼻腔微生物群。
Int J Immunopathol Pharmacol. 2024 Jan-Dec;38:3946320241227103. doi: 10.1177/03946320241227103.
9
Allogeneic Serum Eye Drops: A Randomized Clinical Trial to Evaluate the Clinical Effectiveness of Two Drop Sizes.同种异体血清滴眼液:一项评估两种滴眼液剂量临床疗效的随机临床试验。
Ophthalmol Ther. 2023 Dec;12(6):3347-3359. doi: 10.1007/s40123-023-00827-5. Epub 2023 Oct 16.
10
Low dose or very low dose phenylephrine and cyclopentolate microdrops for retinopathy of prematurity eye examinations (The Little Eye Drop Study): a randomised controlled non-inferiority trial.低剂量或超低剂量苯肾上腺素和环戊酮微滴用于早产儿视网膜病变眼部检查(小滴眼研究):一项随机对照非劣效性试验。
Arch Dis Child Fetal Neonatal Ed. 2023 Jul;108(4):380-386. doi: 10.1136/archdischild-2022-324929. Epub 2023 Jan 2.